相关实验视频
Updated: Jan 18, 2026

04:49
Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
1.0K
在异常发病的嗅觉功能障碍中表现出Lewy体症状和α-Synuclein播种
Oskar Hoffmann McWilliam1, Remarh Bsoul2, Gunhild Waldemar1,3
1Department of Neurology, Danish Dementia Research Centre, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Movement disorders clinical practice
|September 8, 2025
概括
异常嗅觉功能障碍 (IOD) 显示了高水平的α-synuclein沉积 (αSynD) 和早期的莱维体乱 (LBD) 症状. 这表明IOD可以作为早期LBD检测和干预的有价值标志物.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
背景情况:
- 早期识别病态的α-synuclein沉积 (αSynD) 对于理解Lewy体疾病 (LBD) 的进展至关重要.
- 及时诊断可以使LBD的疾病修饰治疗方法的开发成为可能.
研究的目的:
- 用种子放大试验在具有异常嗅觉功能障碍 (IOD) 的个体中研究αSynD.
- 在IOD参与者中评估前进性LBD症状.
主要方法:
- 横截面,病例控制研究,包括IOD参与者和55-75岁的健康对照 (HC).
- 评估了皮肤和嗅觉粘膜中的αSynD,认知功能障碍,快速眼动睡眠行为障碍 (RBD) 和运动/非运动症状 (MDS-UPDRS).
主要成果:
- 41%的IOD参与者 (n=18/44) 是αSynD阳性,而HC的2% (n=1/50) 是αSynD阳性.
- iOD参与者表现出更高的认知功能障碍率 (48%vs.24%),可能的RBD (41%vs.16%),以及较高的MDS-UPDRS分数 (15vs.5.5).
- 45%的IOD参与者符合预发性帕金森病 (PD) 标准.
结论:
- 异常嗅觉功能障碍表现出αSynD和前期LBD症状的高患病率.
- iOD作为潜在的LBD早期标志物和干预研究的模型.
相关概念视频
Olfactory Receptors: Location and Structure
11.2K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
11.2K
Neural Regulation
43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Olfaction
48.2K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
48.2K
Physiology of Smell and Olfactory Pathway
12.4K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
The olfactory...
12.4K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

